BWA
34
5
SLG
31
3
FIS
53
2
DOW
36
2
XRX
34
2
CMS
61
-6
COF
69
4
YUM
57
-2
PH
73
3
PFG
52
-3
TXN
38
3
HST
32
2
GT
51
22
MU
54
8
STI
36
3
CHRW
64
2
AMP
73
3
VRSK
61
-2
CVS
70
-2
LB
53
3
BWA
34
5
SLG
31
3
FIS
53
2
DOW
36
2
XRX
34
2
CMS
61
-6
COF
69
4
YUM
57
-2
PH
73
3
PFG
52
-3
TXN
38
3
HST
32
2
GT
51
22
MU
54
8
STI
36
3
CHRW
64
2
AMP
73
3
VRSK
61
-2
CVS
70
-2
LB
53
3
Financhill
Back

ProShares UltraPro S&P500 Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
56

UPRO
ProShares UltraPro S&P500

Last Price:
$98.59
Seasonality Move:
4.23%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.33
Seasonality Move:
1.75%
Buy
56
ProShares UltraPro S&P500 (UPRO) is a Buy

Is ProShares UltraPro S&P500 a Buy, Sell or Hold?

  • The current ProShares UltraPro S&P500 [UPRO] share price is $97.81. The Score for UPRO is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • UPRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UPRO Stock Price Chart

What is ProShares UltraPro S&P500's stock price today?

  • The ProShares UltraPro S&P500 share price today is $97.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UPRO is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

UPRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1 Buy
Relative Strength Index (14 RSI): 57.18 Buy
Chaikin Money Flow: -821212 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (90.53 - 97.67) Buy
Bollinger Bands (100): (86.83 - 96.45) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

UPRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 96.02 Buy
20-day SMA: 95.64 Buy
50-day SMA: 94.28 Buy
200-day SMA: 83.34 Buy
8-day EMA: 96.22 Buy
20-day EMA: 95.13 Buy
50-day EMA: 93.67 Buy
200-day EMA: 83.56 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

ProShares UltraPro S&P500 Earnings Growth & UPRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

ProShares UltraPro S&P500 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):